Docetaxel-Aggravated Psoriasis

Yang, Seungkeol; Kim, Bo Ri; Choi, Chong Won; Youn, Sang Woong

doi:10.5021/ad.2019.31.2.240

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

A Case Of New-onset Psoriasis During Docetaxel Treatment1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…He was treated with acitretin at a dose of 20 mg daily and topical calcipotriol/betamethasone dipropionate. An improvement in psoriasis lesions began after 10 weeks of treatment [7].…”

Section: Discussionmentioning

confidence: 99%

Psoriasis Flare-Up in a Patient Treated With Docetaxel for Metastatic Prostate Cancer

Kurian¹,

Patell²,

Sekaran³

2023

Cureus

View full text Add to dashboard Cite

Dermatologic toxicities, such as urticaria and mucositis, with docetaxel, have been commonly reported; however, fixed-plaque erythrodysesthesia is a rare adverse phenomenon with a reported incidence of less than 5% of patients. Docetaxel-induced psoriasis is extremely rare, and to date, very few cases have been reported in the literature. We present a literature review of psoriasis cases secondary to docetaxel and report our own case of severe docetaxel-induced psoriasis in the setting of treatment of metastatic prostate cancer. Our patient received topical steroids and narrow-band ultraviolet B (NBUVB) light therapy with resolution of their psoriasis and was able to complete their chemotherapy without discontinuation or interruption of their docetaxel.

show abstract

“…He was treated with acitretin at a dose of 20 mg daily and topical calcipotriol/betamethasone dipropionate. An improvement in psoriasis lesions began after 10 weeks of treatment [7].…”

Section: Discussionmentioning

confidence: 99%

Psoriasis Flare-Up in a Patient Treated With Docetaxel for Metastatic Prostate Cancer

Kurian¹,

Patell²,

Sekaran³

2023

Cureus

View full text Add to dashboard Cite

show abstract

“…To the best of our knowledge, there have been only ve reported cases of docetaxel-induced or docetaxel-aggravated psoriasis (Table 1). [12][13][14][15][16] Among these cases, only two reported patients with no personal or family history of psoriasis or psoriatic arthritis. e latency period between the initiation of docetaxel and the onset of psoriasis ranged from 3 days to 4 months.…”

Section: A Case Of New-onset Psoriasis During Docetaxel Treatmentmentioning

confidence: 99%